Covered recipient · General Payments record
GREGORY BURKHART
Allopathic & Osteopathic Physicians Preventive Medicine Public Health & General Preventive Medicine
General Payments · PY2018–2024
$1,239,295.70
- Reported across 225 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $62,338.74 | 15 |
| Travel and Lodging | $120.38 | 2 |
| Food and Beverage | $29.47 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $19,262.50 | 5 |
| Novo Nordisk AS | $14,945.00 | 3 |
| Eli Lilly and Company | $8,625.00 | 2 |
| Janssen Research & Development, LLC | $7,015.00 | 1 |
| BeiGene USA, Inc. | $4,575.00 | 1 |
| ABBVIE INC. | $3,660.00 | 1 |
| Aurobindo Pharma USA, Inc. | $3,604.41 | 3 |
| Mylan Inc. | $801.68 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $3,660.00 | 09/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1103132505 | CMS |
| Aurobindo Pharma USA, Inc. | $29.47 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154761069 | CMS |
| Aurobindo Pharma USA, Inc. | $60.19 | 09/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154761033 | CMS |
| Aurobindo Pharma USA, Inc. | $3,514.75 | 10/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1153851979 | CMS |
| BeiGene USA, Inc. | $4,575.00 | 09/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1120854801 | CMS |
| Eli Lilly and Company | $1,725.00 | 03/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1134990072 | CMS |
| Eli Lilly and Company | $6,900.00 | 05/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1135014003 | CMS |
| Janssen Research & Development, LLC | $7,015.00 | 02/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1077589461 | CMS |
| JAZZ PHARMACEUTICALS INC. | $3,162.50 | 01/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150238454 | CMS |
| JAZZ PHARMACEUTICALS INC. | $5,893.75 | 02/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150238456 | CMS |
| JAZZ PHARMACEUTICALS INC. | $2,731.25 | 03/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150238458 | CMS |
| JAZZ PHARMACEUTICALS INC. | $3,306.25 | 04/02/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150238462 | CMS |
| JAZZ PHARMACEUTICALS INC. | $4,168.75 | 05/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1150238460 | CMS |
| Mylan Inc. | $60.19 | 09/13/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1147272402 | CMS |
| Mylan Inc. | $741.49 | 10/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1147272282 | CMS |
| Novo Nordisk Inc | $3,660.00 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097838825 | CMS |
| Novo Nordisk Inc | $3,965.00 | 04/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1096716281 | CMS |
| Novo Nordisk Inc | $7,320.00 | 05/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1097496903 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.